Katherine Stueland, CEO: GeneDx Holdings WGS Sell · Filed 24/09/18

Trade details

Type: Insider sale
Amount: $394,732.59
Shares · price: 10,501 sh · $37.59 a share
Held after: 103,706 sh
Stock: GeneDx Holdings WGS
Person: Katherine StuelandCEO
Trade date: 24/09/16
Filed: 24/09/18
Days to filing: 2 days

Sold 9.2% of holdings

Share of holding sold: 9.2%

GeneDx Holdings trades, last 26 weeks

What else happened in GeneDx Holdings around then

Filed or reported within 30 days of the trade day · 24/08/17~24/10/16

Katherine Stueland's recent trades

Katherine StuelandCEO
Planned saleGeneDx Holdings
Planned sale
GeneDx Holdings
WGS
$1.2M
14,243 sh
$1.2M
Filed 09/01
Traded 09/09
Katherine StuelandCEO
SellGeneDx Holdings
Sell
GeneDx Holdings
WGS
$360.8K
5,932 sh
$360.8K
Filed 06/18
Traded 06/16
Katherine StuelandCEO
SellGeneDx Holdings
Sell
GeneDx Holdings
WGS
$149.4K
2,429 sh
$149.4K
Filed 06/18
Traded 06/16
Katherine StuelandCEO
SellGeneDx Holdings
Sell
GeneDx Holdings
WGS
$127.9K
2,140 sh
$127.9K
Filed 06/18
Traded 06/16
Katherine StuelandCEO
SellGeneDx Holdings
Sell
GeneDx Holdings
WGS
$195.7K
3,639 sh
$195.7K
Filed 06/11
Traded 06/09

Katherine Stueland, CEO — sold $394.7K of GeneDx Holdings WGS · 9.2% of holdings | Whalegun